Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and intraprocedural temperature monitoring, thermal dosimetry, bladder irrigation, and magnetic field nanoparticle activation

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The procedure described by CPT® Code 0739T involves the ablation of malignant prostate tissue using a magnetic field induction technique. This innovative approach utilizes a suspension of magnetic nanoparticles that are injected into targeted areas of the prostate tissue. The procedure is designed to effectively destroy tumor cells while preserving surrounding healthy tissue. During the ablation process, the patient remains conscious, allowing them to communicate their sensations and comfort levels to the physician, which is crucial for ensuring patient safety and comfort throughout the procedure. The physician relies on preoperative imaging, such as MRI, along with ultrasound guidance, to accurately place the necessary catheters that will hold temperature sensors for real-time monitoring during the treatment. The procedure also includes bladder irrigation, which is initiated to protect the bladder during the injection of the nanoparticle suspension. This irrigation continues until it is confirmed that no nanoparticles are present in the urethra, indicating that the procedure can proceed safely. The temperature sensors are strategically placed through the catheters to monitor the tissue temperature closely, ensuring that it remains within the target range necessary for effective ablation. The magnetic field is activated for approximately one hour, during which the physician continuously monitors the tissue temperatures to achieve successful tumor ablation.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The procedure described by CPT® Code 0739T is indicated for the treatment of malignant prostate tissue. This technique is specifically utilized for patients diagnosed with prostate cancer, where traditional treatment options may not be suitable or effective. The use of magnetic field induction for ablation is particularly relevant for tumors that are localized within the prostate and can benefit from targeted thermal destruction while minimizing damage to surrounding healthy tissue.

  • Malignant Prostate Tissue The primary indication for this procedure is the presence of malignant tumors within the prostate gland, which require intervention to reduce tumor size or eliminate cancerous cells.

2. Procedure

The procedure for CPT® Code 0739T involves several critical steps to ensure effective ablation of malignant prostate tissue. Each step is meticulously planned and executed to maximize patient safety and treatment efficacy.

  • Step 1: Preoperative Planning The procedure begins with preoperative imaging, typically using MRI, to identify the precise location of the malignant tissue within the prostate. This imaging is essential for planning the treatment and determining the optimal placement of catheters for temperature monitoring.
  • Step 2: Catheter Placement Under ultrasound guidance, the physician places transperineal needles or catheters into the previously identified target regions of the prostate. These catheters are designed to hold temperature sensors that will monitor the tissue during the ablation process.
  • Step 3: Bladder Irrigation To protect the bladder during the procedure, bladder irrigation is initiated. This involves the infusion of fluid into the bladder to ensure that it is adequately flushed and to prevent any potential complications during the injection of the nanoparticle suspension.
  • Step 4: Nanoparticle Injection Once the catheters are in place and bladder irrigation is established, a suspension of magnetic nanoparticles is injected into the targeted prostate tissue. This step is crucial as the nanoparticles will be activated by the magnetic field to facilitate tumor ablation.
  • Step 5: Temperature Sensor Placement After the nanoparticle injection, temperature sensors are placed through the catheters. These sensors are essential for monitoring the temperature of the tissue during the ablation process to ensure it remains within the target range for effective treatment.
  • Step 6: Activation of Magnetic Field The magnetic field is then activated, typically for a duration of approximately one hour. During this time, the physician continuously monitors the tissue temperatures to ensure they remain within the desired range for successful ablation of the malignant tissue.

3. Post-Procedure

Following the completion of the ablation procedure, patients are monitored for any immediate post-procedural effects. It is essential to assess the patient's comfort level and any potential complications that may arise from the procedure. The physician will typically provide instructions regarding post-procedure care, which may include recommendations for hydration, activity restrictions, and follow-up appointments to evaluate the effectiveness of the treatment. Additionally, monitoring for any signs of infection or adverse reactions is crucial in the days following the procedure to ensure patient safety and recovery.

Short Descr ABLTJ MAL PRST8 MAG FLD NDCT
Medium Descr ABLATION MAL PRST8 TISS MAGNETIC FIELD INDUCTION
Long Descr Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and intraprocedural temperature monitoring, thermal dosimetry, bladder irrigation, and magnetic field nanoparticle activation
Status Code Carriers Price the Code
Global Days YYY - Carrier Determines Whether Global Concept Applies
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 2 - Standard payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 2 - Payment restriction for assistants at surgery does not apply to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Non-Covered Service, not paid under OPPS
Berenson-Eggers TOS (BETOS) none
MUE 1
Date
Action
Notes
2023-01-01 Added Code added.
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"